Diabetes
A large study has found that medications like Ozempic, Wegovy, and Trulicity, which are used to treat diabetes and aid weight loss, may also reduce the risk of heart attacks, strokes, and death from heart disease. These findings, published in the Journal of the American College of Cardiology in 2025,
Diabetes
GLP-1 medications like semaglutide (Ozempic/Wegovy), liraglutide, dulaglutide, and others have become some of the most popular treatments for type 2 diabetes and weight loss. Millions of people now use these medicines every month. Because so many adults are starting GLP-1 drugs, it is more important than ever to understand
Diabetes
What Did the Research Discover? Scientists conducted a study to see if a medication called tirzepatide could help people maintain and further their weight loss after an intensive diet and exercise program. The study included 579 adults who were overweight or obese but did not have diabetes. Before starting the
Diabetes
Can medications for type 2 diabetes also protect the brain? A new meta-analysis published in Movement Disorders Clinical Practice combined results from 24 clinical trials—and found a possible link between newer diabetes medications and a lower risk of Parkinson’s disease.
Diabetes
What Did the Research Discover? This study explored the relationship between chronotype (morning vs. evening preference) and the risk of developing type 2 diabetes in middle-aged nurses. The findings suggest that nurses with an evening chronotype—those who naturally stay up late and wake up later—are more likely to
Diabetes
What Did the Research Discover? This study investigated whether lifestyle interventions (LI) for preventing type 2 diabetes are equally effective for all individuals with prediabetes or if different approaches are needed based on individual risk levels. The researchers categorized participants into low-risk (LR) and high-risk (HR) phenotypes based on factors
Diabetes
What Did the Research Discover? This study explored whether stopping metformin therapy—particularly for reasons unrelated to kidney dysfunction—was linked to an increased risk of developing dementia. Researchers analyzed data from Kaiser Permanente Northern California, following over 41,000 metformin users for up to 24 years. The findings revealed
Diabetes
What is this alert about? In April 2025, the drug company Novo Nordisk told the U.S. Food and Drug Administration (FDA) that fake versions of Ozempic (semaglutide) were found in the U.S. drug supply. Ozempic is a prescription medicine used to help adults with type 2 diabetes lower
Diabetes
What Did the Research Discover? A systematic review and meta-analysis examined how well semaglutide helps people lose weight if they are obese or overweight but do not have diabetes. Researchers analyzed data from eight clinical trials with 4,567 participants, comparing semaglutide to a placebo. The results showed that semaglutide
Diabetes
What Did the Research Discover? Scientists developed a new type of glucose sensor called a BioTFT (Biosensing Thin-Film Transistor) that can detect glucose in saliva instead of blood. This technology is non-invasive, meaning it does not require a blood sample, and it provides results in less than 60 seconds. The
Diabetes
What Did the Research Discover? Menopausal vasomotor symptoms (VMS)—such as hot flashes and night sweats—are common experiences for many women during menopause. While previous research has established a link between obesity and the presence of menopausal symptoms, this study sought to explore whether the severity of these symptoms
Diabetes
What Did the Research Discover? Researchers investigated whether low-dose aspirin could reduce the risk of developing type 2 diabetes in older adults. The study included 16,209 people aged 70 and older (or 65 and older for some U.S. minority groups) who were generally healthy and did not have